A COMPOSITION FOR IMPROVING LIPID METABOLISM AND INHIBITING FAT ACCUMULATION CONTAINING DIPEPTIDES OF WE OR WR

摘要

The present invention relates to a pharmaceutical composition or a food containing dipeptide WE or WR as an active ingredient and, more specifically, to a pharmaceutical composition or a food containing dipeptide WE or WR as an active ingredient, capable of effectively reducing neutral lipid or cholesterol concentrations in blood or liver by activating peroxisome proliferator-activated protein α (PPAR α), particularly, which is closely related to life-habit disease and metabolic syndrome, and inhibiting fat accumulation, or treating or alleviating fatty liver by improving lipid metabolism inside a body.